Treatment of MOG antibody associated disorders: results of an international survey

ConclusionCurrent treatment of MOGAD is highly variable, indicating a need for consensus-based treatment guidelines, while awaiting definitive clinical trials.

Source: Journal of Neurology - July 3, 2020 Category: Neurology Source Type: research